These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 14123065

  • 1. [LIPIDS AND LIPINS OF THE HYPOTHALAMIC REGION. IV. CHROMATOGRAPHIC FRACTIONATION OF HYPOTHALAMIC PHOSPHOLIPIDS AND IDENTIFICATION OF AN ACTH-TROPHIC FACTOR DIFFERENT FROM GUILLEMIN'S CORTICOTROPHIN RELEASING FACTOR (CRF)].
    CURRI SB, RIPA R.
    Riv Anat Patol Oncol; 1963 Sep; 24():311-39. PubMed ID: 14123065
    [No Abstract] [Full Text] [Related]

  • 2. Immunoreactive corticotropin and corticotropin-releasing factor in human hypothalamus, adrenal, lung cancer, and pheochromocytoma.
    Suda T, Tomori N, Tozawa F, Demura H, Shizume K, Mouri T, Miura Y, Sasano N.
    J Clin Endocrinol Metab; 1984 May; 58(5):919-24. PubMed ID: 6323518
    [Abstract] [Full Text] [Related]

  • 3. [ACTH-RELEASING ACTIVITY OF A HYPOTHALAMIC PHOSPHOLIPID FACTOR].
    CURRI SB, BARBERINI E, VECCHIA P.
    G Psichiatr Neuropatol; 1964 May; 92():447-63. PubMed ID: 14217819
    [No Abstract] [Full Text] [Related]

  • 4. Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides.
    Buckingham JC.
    Neuroendocrinology; 1982 May; 35(2):111-6. PubMed ID: 6290921
    [Abstract] [Full Text] [Related]

  • 5. Inhibitory effect of adrenocorticotropin on corticotropin- releasing factor release from rat hypothalamus in vitro.
    Suda T, Yajima F, Tomori N, Sumitomo T, Nakagami Y, Ushiyama T, Demura H, Shizume K.
    Endocrinology; 1986 Jan; 118(1):459-61. PubMed ID: 3000747
    [Abstract] [Full Text] [Related]

  • 6. HANS SELYE AND THE STRESS RESPONSE: FROM "THE FIRST MEDIATOR" TO THE IDENTIFICATION OF THE HYPOTHALAMIC CORTICOTROPIN-RELEASING FACTOR.
    Tachè Y.
    Ideggyogy Sz; 2014 Mar 30; 67(3-4):95-8. PubMed ID: 26118248
    [Abstract] [Full Text] [Related]

  • 7. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia.
    Engler D, Pham T, Fullerton MJ, Ooi G, Funder JW, Clarke IJ.
    Neuroendocrinology; 1989 Apr 30; 49(4):367-81. PubMed ID: 2541360
    [Abstract] [Full Text] [Related]

  • 8. Two distinct corticotrophin releasing activities of vasopressin.
    Buckingham JC.
    Br J Pharmacol; 1985 Jan 30; 84(1):213-9. PubMed ID: 2983801
    [Abstract] [Full Text] [Related]

  • 9. Responsiveness of adenohypophysial corticotrophs to hypothalamic (SME) extract remains unchanged in rats with hypothalamic lesions inhibiting CRF release.
    Stark E, Kárteszi M, Makara GB.
    Neuroendocrinology; 1983 May 30; 36(5):330-4. PubMed ID: 6304553
    [Abstract] [Full Text] [Related]

  • 10. Comparative chromatography of hypothalamic corticotrophin-releasing factors.
    Gillies GE, Puri A, Linton EA, Lowry PJ.
    Neuroendocrinology; 1984 Jan 30; 38(1):17-24. PubMed ID: 6607424
    [Abstract] [Full Text] [Related]

  • 11. Mice that lack corticotropin-releasing factor (CRF) receptors type 1 show a blunted ACTH response to acute alcohol despite up-regulated constitutive hypothalamic CRF gene expression.
    Lee S, Smith GW, Vale W, Lee KF, Rivier C.
    Alcohol Clin Exp Res; 2001 Mar 30; 25(3):427-33. PubMed ID: 11290855
    [Abstract] [Full Text] [Related]

  • 12. Corticotrophin-releasing factors in the hypothalamus of the developing fetal sheep.
    Currie IS, Brooks AN.
    J Dev Physiol; 1992 May 30; 17(5):241-6. PubMed ID: 1281183
    [Abstract] [Full Text] [Related]

  • 13. Rat hypothalamic corticotropin-releasing factor (CRF) content remains constant despite marked acute or chronic changes in ACTH secretion.
    Yasuda N, Greer MA.
    Neuroendocrinology; 1976 May 30; 22(1):48-56. PubMed ID: 193065
    [Abstract] [Full Text] [Related]

  • 14. Persistence of a diurnal rhythm in hypothalamic corticotrophin-releasing factor (CRF) in the absence of hormone feedback.
    Seiden G, Brodish A.
    Endocrinology; 1972 May 30; 90(5):1401-3. PubMed ID: 4335098
    [No Abstract] [Full Text] [Related]

  • 15. Assay of corticotrophin releasing factor (CRF) in ACTH-primed 'grafted' rats.
    Sirett NE, Purves HD.
    Neuroendocrinology; 1972 May 30; 10(2):83-93. PubMed ID: 4340091
    [No Abstract] [Full Text] [Related]

  • 16. A different distribution of corticotropin releasing factor and arginine vasopressin contents in the hypothalamic nuclei after estrogen administration.
    Hashimoto K, Ohno N, Aoki Y, Kageyama J, Takahara J, Ofuji T.
    Acta Med Okayama; 1981 Feb 30; 35(1):37-43. PubMed ID: 6266205
    [Abstract] [Full Text] [Related]

  • 17. [Hypothalamic control of ACTH secretion].
    Oliver C, Conte-Devolx B, Giraud P, Gillioz P, Lissitzky JC, Boudouresque F.
    Horm Res; 1980 Feb 30; 13(4-5):230-41. PubMed ID: 6268511
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin II and adrenocorticotropin release: mediation by endogenous corticotropin-releasing factor.
    Spinedi E, Rodriguez G.
    Endocrinology; 1986 Sep 30; 119(3):1397-402. PubMed ID: 3015575
    [Abstract] [Full Text] [Related]

  • 19. [Functional maturation of the human corticotropin releasing factor-adrenocorticotropic hormone system during intrauterine life. An in vitro study].
    Dévai AT, Kuznetsova LV, Stark E, Bukulya B, Acs Zs.
    Biull Eksp Biol Med; 1982 Jul 30; 94(7):88-91. PubMed ID: 6289934
    [Abstract] [Full Text] [Related]

  • 20. [Hypothalamic factors: current findings].
    Sizonenko PC.
    Schweiz Med Wochenschr; 1986 Mar 01; 116(9):271-4. PubMed ID: 3006238
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.